| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a12885ea105b0ad171910f0b6fda5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a90ae821bcbf2004901b7dcdb6f746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b2b0bea90373d33540cbc22d39db384
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a436b9bac24486364ac8bfe1505cd1d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c1c8e9632ae99b4b36458597295a56c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee9adbd5b1287f4279a79f4a08a3c08a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79faaa36863f46d3354f6064184246f0 |
| publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
MX-2008011791-A |
| titleOfInvention |
AZACICLILAMINAS-N-SUBSTITUTED AS ANTAGONISTS OF HISTAMINE-3. |
| abstract |
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the histamine-3 receptor. (see formula (I)). |
| priorityDate |
2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |